MariMed To Launch Hemp-Derived THC Products, Introducing Its Top-Selling Brands to New Markets and Customers

NORWOOD, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, today announced manufacturing and distribution agreements that enable the Company to launch their market leading beverage and edibles brands, including and , into the rapidly growing hemp-derived THC market.

This initiative is part of MariMed’s broader Expand the Brand strategy to extend its award-winning portfolio into new categories and markets nationwide.

A hemp-derived THC version of the Company’s Vibations hydrating drink mix is expected to be the first product available to consumers, with anticipated distribution in Rhode Island by the early first quarter of 2026. According to BDSA and Lit Alerts, Vibations is a top 10 selling cannabis beverage brand in Illinois, Massachusetts, Maryland, and Delaware.

The Company is also developing distribution plans in additional markets for Vibations and Betty’s Eddies, which consistently rank among the top-selling cannabis edibles in all of MariMed’s core markets.

The agreements announced today establish a strong, end-to-end hemp THC supply chain for the Company. According to BDSA, the hemp beverage space alone generated $3.3 billion in 2024 and is projected to nearly double by 2029. To capture share of the market, MariMed has partnered with proven leaders for manufacturing, wholesale distribution, and marketing:

• , known for its advanced technology for rapid onset and shelf stability of cannabis products;
  
  
• , a national sales and marketing firm best known for its successful partnerships with Poppi soda, Kendall Jenner’s 818 Tequila and many other well-known and respected brands, will provide Market Sales Reps, National Account Coverage and Market Expansion Services; and
  
  
• , the leading hemp beverage distributor in Rhode Island.
  
  

“We intend to own top-selling, national cannabis brands within the next five years, and the regulated hemp THC space provides a great opportunity to support that goal by introducing our brands to the masses,” said MariMed CEO Jon Levine. “As always, we are taking a financially disciplined approach to our entry, carefully investing in our entry and working with respected leaders in the space to help drive this new revenue channel for the Company.”

The Company has established a new business unit, MMA Hemp Inc., to operate its hemp-derived THC activities.

ABOUT MARIMED

MariMed Inc. is a leading multi-state cannabis operator, known for developing and managing state-of-the-art cultivation, production, and retail facilities. Our award-winning portfolio of cannabis brands, including Betty's Eddies™, Bubby’s Baked™, Vibations™, InHouse™, and Nature’s Heritage™, sets us apart as an industry leader. These trusted brands, crafted with quality and innovation, are recognized and loved by consumers across the country. With a commitment to excellence, MariMed continues to drive growth and set new standards in the cannabis industry. For additional information, visit .

IMPORTANT CAUTION REGARDING FORWARD-LOOKING STATEMENTS:

The information in this release contains “forward-looking” statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, which are subject to several risks and uncertainties. All statements other than statements of historical facts contained in this release, including without limitation statements regarding projected financial results for 2025, including anticipated openings of dispensaries and facilities, timing of regulatory approvals, plans and objectives of management for future operations, are forward-looking statements. Without limiting the foregoing, the words “anticipates”, “believes”, “estimates”, “expects”, “expectations”, “intends”, “may”, “plans”, and other similar language, whether in the negative or affirmative, are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words.

Forward-looking statements are based on our current beliefs and assumptions regarding our business, timing of regulatory approvals, the ability to obtain new licenses, permits, business prospects and strategic growth plan, and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated in these forward-looking statements due to various risks, uncertainties, and other important factors, including, among others, reductions in customer spending, our ability to recruit and retain key personnel, and disruptions from the integration efforts of acquired companies.

These factors are not intended to be an all-encompassing list of risks and uncertainties that may affect our business and results of operations. These statements are not a guarantee of future performance and involve risk and uncertainties that are difficult to predict, including, among other factors, changes in demand for the Company’s services and products, changes in the law and its enforcement, and changes in the economic environment. Additional information regarding these and other factors can be found in our reports filed with the U.S. Securities and Exchange Commission. In providing these forward-looking statements, the Company expressly disclaims any obligation to update these statements publicly or otherwise, whether as a result of new information, future events or otherwise, except as required by law.

All trademarks and service marks are the property of their respective owners.

MariMed Company Contact:

Howard Schacter, Chief Communications Officer

Email:

Phone: (781) 277-0007